C-J Advisory’s Quest Diagnostics DGX Stock Holding History

C-J Advisory’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-216	Closed	-$23K	–	72
2019 Q3	$23K	Hold	216	–	–	0.01%	83
2019 Q2	$22K	Hold	216	–	–	0.01%	83
2019 Q1	$19K	Hold	216	–	–	0.01%	113
2018 Q4	$18K	Hold	216	–	–	0.01%	82
2018 Q3	$23K	Hold	216	–	–	0.02%	77
2018 Q2	$24K	Hold	216	–	–	0.02%	77
2018 Q1	$21K	Hold	216	–	–	0.02%	80
2017 Q4	$21K	Sell	216 -91	-30%	-$8.63K	0.02%	73
2017 Q3	$29K	Sell	307 -32	-9%	-$3.4K	0.02%	54
2017 Q2	$38K	Buy	339 +40	+13%	+$4.23K	0.03%	44
2017 Q1	$29K	Hold	299	–	–	0.02%	51
2016 Q4	$27K	Hold	299	–	–	0.02%	55
2016 Q3	$25K	Buy	+299	New	+$25.1K	0.02%	57

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

C-J Advisory's DGX Position: Q4 2019 in Review

C-J Advisory sold out of Quest Diagnostics (DGX) in Q4 2019, closing a stake of 216 shares — an estimated $23K sold.

C-J Advisory first reported a position in DGX in Q3 2016 and held it in 13 quarters. The position peaked at $38K in Q2 2017. 711 funds tracked by Wall St. Rank hold DGX as of Q4 2019.

C-J Advisory reported no remaining Quest Diagnostics position as of Q4 2019 after selling out during the quarter.
C-J Advisory sold 216 Quest Diagnostics shares in Q4 2019, an estimated $23K.
C-J Advisory first reported a position in Quest Diagnostics in Q3 2016 and held it in 13 quarters.
C-J Advisory's Quest Diagnostics position peaked at $38K in Q2 2017.
711 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2019.

Based on C-J Advisory's 13F filing for Q4 2019, filed 10 Feb 2020.